ABOUT DR. SHER
Neal A. Sher, MD, FACS
A New York native, Dr. Sher received his BA and MD degrees with honors from Boston University at age 22. After an internship at the University of Minnesota Hospitals, he joined the U.S. Public Health Service in 1972, serving as a Staff Associate in the FDA's Division of Biologic Standards, housed on the NIH campus in Bethesda, Maryland. Over the next three years, he conducted tumor immunology and immunotherapy research using BCG vaccine as a cancer treatment agent, authoring a number of papers in the field. There he grew interested in ocular immunology and switched into ophthalmology, completing his residency at the University of Minnesota and a fellowship in corneal and external disease at Moorfields Eye Hospital in London. Returning to Minneapolis in 1979, he entered private practice with the group that became Eye Care Associates, which grew to 65 employees across several offices. He left clinical practice in Minneapolis in June 2020 and relocated to Chicago.
Dr. Sher was a founding member and attending surgeon at the Phillips Eye Institute (1987), later serving as Chief of Ophthalmology. Phillips grew into one of the nation's highest-volume eye surgery centers before its clinical services were consolidated into the Abbott Northwestern Hospital campus in 2022, where the Phillips Eye Institute name continues today as a hospital department. He was on the adjunct faculty of the University of Minnesota Medical School from 1979 to 2021, achieving the rank of Adjunct Clinical Professor, and in 2022 became an Adjunct Lecturer in Ophthalmology at Northwestern University Medical School.
Surgery, Research & Publications
Since 1980, Dr. Sher has performed thousands of anterior segment surgeries, including cataract and corneal transplant procedures, and has devoted considerable time to refractive surgery, holding several related patents. He has authored or co-authored more than 70 scientific papers, book chapters, and journal reviews. In 1994, he became the first American to receive the Troutman Prize from the International Society of Refractive Surgery, recognized for his paper on pain control using diclofenac following PRK. He edited the textbooks Surgery for Hyperopia and Presbyopia and Surgery for Hyperopia, authored a monograph on post-PRK care, and edited an Atlas of Refractive Surgery for the American Academy of Ophthalmology (AAO).
Dr. Sher also holds several device- and pharmaceutical-related patents and has extensive experience with patent proceedings and trials, both in federal court and before the Patent Trial and Appeal Board (PTAB).
He has served as principal investigator or co-investigator on numerous ophthalmologic drug and device clinical trials, consulted for several ophthalmic companies, and served on the AAO's Preferred Practice Patterns Panel for Refractive Errors and Refractive Surgery, as well as on the editorial boards of various ophthalmic publications.
Litigation & Injury Experience
Dr. Sher brings extensive litigation experience across the full range of eye injury cases — from auto accidents, workplace incidents, and criminal assaults to injuries caused by defective consumer products such as contaminated eyedrops. He also has substantial experience evaluating eye injuries resulting from mass exposure to ammonia, chlorine, and other toxic chemicals. In addition, he has been involved in both the clinical care and subsequent litigation of eye injuries caused by non-lethal projectiles used in law enforcement.
Community Service
Among his proudest professional achievements, he donated laser vision correction surgery to more than 900 National Guard and Reserve soldiers deploying to Iraq and Afghanistan — helping them serve without the burden of glasses or contacts in combat conditions. His contribution has been recognized with numerous honors from military units and the National Guard.
A link to a local CBS news segment on this work with the military is below